MedTrace Logo

FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study

NCT02984423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 471

Last updated 2020-07-10

No results posted yet for this study

Summary

This study aims to answer very important questions regarding the prevalence of somatic and germline mutations (sBRCAm and gBRCAm) in a population of newly diagnosed ovarian cancer patients from Latin America. These answers may be extremely helpful in the counseling for genetic risk and treatment approach in these populations and will aid in making treatment decisions in the future

Conditions

Sponsors & Collaborators

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-27
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Argentina
  • Brazil
  • Colombia
  • Mexico
  • Panama
  • Peru

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02984423 on ClinicalTrials.gov